20
Ctx Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is METOPROLOL SUCCINATE USP, with a corresponding US DMF Number 21732.
Remarkably, this DMF maintains an Active status since its submission on June 14, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 15, 2013, and payment made on January 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II